China has been a place for controversial place to do business lately because of the issues surrounding this manufacturing hub.

Despite of such controversies, Pharmaceutical outsourcing in China was given a green light by one of the biggest Pharmaceutical companies in the world which is GlaxoSmithKline. There are two main functions in outsourcing Pharmaceutical tasks in China. These two main tasks are:

-Being a service provider
-Being a drug developer

The Chinese government in return is developing different policie which would accommodate this kind of outsourcing in their country as well as leaving them room for further growth and development. Dr Luo Ying, president and CEO of Shanghai Genomics shared the country' main goal stating that "China's goal is not to be a service lab for the rest of the world. The government wants to encourage the development of domestic IP."

I am still doubtful if China would reach their goal partly because of the issues which they have to face today in accordance with their "quality" work.